Physician profile
Lori Smith
NPI 1558731158
$2,851.24
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,604 · 2022: $1,234 · 2023: $13.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.12 | 2021-2023 | |
| Novo Nordisk INC | $361.91 | 2021-2022 | |
| Lilly USA, LLC | $352.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $217.60 | 2021-2022 | |
| Amgen INC. | $208.70 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $199.59 | 2022 | |
| Kaleo, INC. | $165.05 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $159.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.64 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $92.56 | 2021-2022 | |
| Pfizer INC. | $80.82 | 2021-2022 | |
| Dexcom, INC. | $71.55 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $66.99 | 2021-2022 | |
| Abbott Laboratories | $63.67 | 2022 | |
| Glaxosmithkline, LLC. | $62.01 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $54.72 | 2021 | |
| Vivus LLC | $47.28 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.65 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $35.25 | 2021 | |
| Ibsa Pharma INC. | $34.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.92 | 2022 | |
| Merck Sharp & Dohme LLC | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.